AURORA, Colorado, Sept. 14 [Category: Medical] -- The International Association for the Study of Lung Cancer posted the following news release:

* * *

Study Identifies Distinct Outcomes and Genomic Features in NSCLC With Class II and III BRAF Alterations

*

(SEOUL, Republic of Korea -Tuesday, September 15th, 9:45 a.m. Korea Standard Time) -Patients with metastatic non-small cell lung cancer (NSCLC) harboring class II and class III BRAF alteration . . .

Click here for more information about our products